Therapie des komplizierten Ulkus

J. F. Riemann; G. Bolz

doi:10.1055/s-2002-35892

Zeitschrift für Gastroenterologie, Table of Contents

Z Gastroenterol 2002; 40(S2): 20-23
DOI: 10.1055/s-2002-35892

Supplement

Therapie des komplizierten Ulkus

Blutung, Perforation und Obstruktion durch benigne entzündliche oder postentzündliche StenosenJ. F. Riemann, G. Bolz

¹Medizinische Klinik C (Direktor: Prof. Dr. J. F. Riemann), Gastroenterologie, Hepatologie und Diabetologie, Klinikum der Stadt Ludwigshafen gGmbH, Akademisches Lehrkrankenhaus der Johannes-Gutenberg-Universität Mainz

Abstract

Full Text

References

Literatur

1 Peura D A, Lanza F L, Gostout C J. et al . The American College of Gastroenterology Bleeding Registry: preliminary findings. Am J Gastroenterol. 1997; 92 (6) 924-928
2 Rockall T A, Logan R F, Devlin H B. et al . Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ. 1995; 311 (6999) 222-226
3 Vreeburg E M, Snel P, de Bruijne J W. et al . Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol. 1997; 92 (2) 236-243
4 Czernichow P, Hochain P, Nousbaum J B. et al . Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol. 2000; 12 (2) 175-181
5 Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology. 2001; 120 (3) 594-606
6 de Abajo F J, Garcia R odriguez LA. Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clin Pharmacol. 2001; 1 (1) 1
7 Selby N M, Kubba A K, Hawkey C J. Acid suppression in peptic ulcer haemorrhage: a ‘meta-analysis’. Aliment Pharmacol Ther. 2000; 14 (9) 1119-1126
8 Lau J Y, Sung J J, Lee K K. et al . Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000; 343 (5) 310-316
9 Vreeburg E M, Levi M, Rauws E A. et al . Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppression. Aliment Pharmacol Ther. 2001; 15 (5) 639-646
10 Ell C, Hagenmueller F, Schmitt W. et al . Mulitcenter prespective study of the current status of treatment for bleeding ulcer in Germany. Dtsch Med Wochenschr. 1995; 120 (1-2) 3-9
11 Chung I K, Kim E J, Lee M S, Kim H S. et al . Bleeding Dieulafoy’s lesions and the choice of endoscopic method: comparing the hemostatic efficacy of mechanical and injection methods. Gastrointest Endosc. 2000; 52 (6) 721-724
12 Jensen D M, Kovacs T O, Jutabha R. et al . Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology. 2002; 123 (2) 407-413
13 Kohler B, Maier M, Benz C. et al . Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy. Dig Dis Sci. 1997; 42 (7) 1370-1374
14 Cocks J R. Perforated peptic ulcer-the changing scene. Dig Dis. 1992; 10 (1) 10-16
15 Stabile B E. Surgical treatment of peptic ulceration. Curr Opin Gen Surg. 1993; 206-215
16 Hermansson M, von Stael H olstein C, Zilling T. Peptic ulcer perforation before and after the introduction of H2-receptor blockers and proton pump inhibitors. Scand J Gastroenterol. 1997; 32 (6) 523-529
17 Sanchez-Bueno F, Marin P, Rios A. et al . Has the incidence of perforated peptic ulcer decreased over the last decade?. Dig Surg. 2001; 18 (6) 444-447; discussion 447-448
18 Paimela H, Joutsi T, Kiviluoto T. et al . Recent trends in mortality from peptic ulcer disease in Finland. Dig Dis Sci. 1995; 40 (3) 631-635
19 Svanes C, Soreide J A, Skarstein A. et al . Smoking and ulcer perforation. Gut. 1997; 41 (2) 177-180
20 Doll R, Peto R, Wheatley K. et al . Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ. 1994 Oct; 309 (6959) 901-911
21 Evans J M, McMahon A D, McGilchrist M M. et al . Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ. 1995; 311 (6996) 22-26
22 Garcia R odriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994; 343 (8900) 769-772
23 Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology. 1993; 105 (4) 1078-1088
24 Svanes C, Ovrebo K, Soreide O. Ulcer bleeding and perforation: non-steroidal anti-inflammatory drugs or Helicobacter pylori. Scand J Gastroenterol Suppl. 1996; 220 128-131
25 Sharma A K, Mittal S, Malvi S K. Association of Helicobacter pylori with peptic perforation in Chattisgarh region of India. Trop Gastroenterol. 2000; 21 (1) 42-43
26 Ng E K, Lam Y H, Sung J J. et al . Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg. 2000; 231 (2) 153-158
27 Bergamaschi R, Marvik R, Johnsen G. et al . Open vs laparoscopic repair of perforated peptic ulcer. Surg Endosc. 1999; 13 (7) 679-682
28 Siu W T, Leong H T, Law B K. et al . Laparoscopic repair for perforated peptic ulcer: a randomized controlled trial. Ann Surg. 2002; 235 (3) 313-319
29 Kirstensen E S. Conservative treatment of 155 cases of perforated peptic ulcer. Acta Chir Scand. 1980; 146 189
30 Crofts T J, Park K G, Steele R J. et al . A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med. 1989; 320 (15) 970-973
31 Becker H D. Chirurgische Therapie der Ulkusperforation. Chirurgische Gastroenterologie, Bd. 2 Berlin; Springer 1990: 834-837
32 Boey J, Branicki F J, Alagaratnam T T. et al . Proximal gastric vagotomy. The preferred operation for perforations in acute duodenal ulcer. Ann Surg. 1988; 208 (2) 169-174
33 Gisbert J P, Pajares J M. Helicobacter pyloriinfection and gastric outlet obstruction - prevalence of the infection and role of antimicrobial treatment. Aliment Pharmacol Ther. 2002; 16 (7) 1203-1208
34 Brandimarte G, Tursi A, di Cesare L. et al . Antimicrobial treatment for peptic stenosis: a prospective study. Eur J Gastroenterol Hepatol. 1999; 11 (7) 731-734
35 Taskin V, Gurer I, Ozyilkan E. et al . Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction. Helicobacter. 2000; 5 (1) 38-40
36 Boylan J J, Gradzka M I. Long-term results of endoscopic balloon dilatation for gastric outlet obstruction. Dig Dis Sci. 1999; 44 (9) 1883-1886
37 Hewitt P M, Krige J E, Funnell I C. et al . Endoscopic balloon dilatation of peptic pyloroduodenal strictures. J Clin Gastroenterol. 1999; 28 (1) 33-35
38 Lam Y, Lau J Y, Law K B. et al . Endoscopic balloon dilation and Helicobacter pylori eradication in the treatment of gastric outlet obstruction. Gastrointest Endosc. 1997; 46 (4) 379-380
39 Schilling D, Martin W R, Benz C. et al . Long-term results of endoscopic balloon dilatation of ulcer-induced pyloric stenoses - follow-up of 25 patients. Z Gastroenterol. 1997; 35 (2) 105-108
40 Persson S T, Fraser A G, Lane M R. Long-term follow-up of the management of benign oesophageal strictures at Auckland Hospital 1990-1994. N Z Med J. 1999; 112 (1081) 28-30

Prof. Dr. J. F. Riemann

Medizinische Klinik C, Klinikum der Stadt Ludwigshafen gGmbH

Bremserstraße 79

67063 Ludwigshafen am Rhein

Email: MedCLu@t-online.de